141 related articles for article (PubMed ID: 36801992)
1. Magnetic resonance imaging diagnosis of non-mass enhancement of the breast.
Kubota K; Mori M; Fujioka T; Watanabe K; Ito Y
J Med Ultrason (2001); 2023 Jul; 50(3):361-366. PubMed ID: 36801992
[TBL] [Abstract][Full Text] [Related]
2. The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.
Aydin H
Br J Radiol; 2019 Apr; 92(1096):20180464. PubMed ID: 30673299
[TBL] [Abstract][Full Text] [Related]
3. Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI.
Chen ST; Covelli J; Okamoto S; Daniel BL; DeMartini WB; Ikeda DM
Br J Radiol; 2021 Feb; 94(1118):20201166. PubMed ID: 33332980
[TBL] [Abstract][Full Text] [Related]
4. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
5. Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast.
Cho YH; Cho KR; Park EK; Seo BK; Woo OH; Cho SB; Bae JW
Iran J Radiol; 2016 Jan; 13(1):e30909. PubMed ID: 27127579
[TBL] [Abstract][Full Text] [Related]
6. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
Chikarmane SA; Michaels AY; Giess CS
AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
[TBL] [Abstract][Full Text] [Related]
7. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
[TBL] [Abstract][Full Text] [Related]
8. Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI.
Jirarayapong J; Chikarmane SA; Portnow LH; Farah S; Gombos EC
J Magn Reson Imaging; 2024 May; 59(5):1725-1739. PubMed ID: 37534882
[TBL] [Abstract][Full Text] [Related]
9. Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.
de Faria Castro Fleury E; Castro C; do Amaral MSC; Roveda Junior D
Breast Cancer (Auckl); 2022; 16():11782234221095897. PubMed ID: 35602239
[TBL] [Abstract][Full Text] [Related]
10. Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy.
Asada T; Yamada T; Kanemaki Y; Fujiwara K; Okamoto S; Nakajima Y
Jpn J Radiol; 2018 Mar; 36(3):200-208. PubMed ID: 29285740
[TBL] [Abstract][Full Text] [Related]
11. Categorization of non-mass-like breast lesions detected by MRI.
Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.
Kim Y; Jung HK; Park AY; Ko KH; Jang H
Acta Radiol; 2022 Aug; 63(8):1032-1042. PubMed ID: 34260322
[TBL] [Abstract][Full Text] [Related]
13. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
[TBL] [Abstract][Full Text] [Related]
14. Patterns of malignant non-mass enhancement on 3-T breast MRI help predict invasiveness: using the BI-RADS lexicon fifth edition.
Lee SM; Nam KJ; Choo KS; Kim JY; Jeong DW; Kim HY; Kim JY
Acta Radiol; 2018 Nov; 59(11):1292-1299. PubMed ID: 29758996
[TBL] [Abstract][Full Text] [Related]
15. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors.
Tozaki M; Fukuda K
AJR Am J Roentgenol; 2006 Aug; 187(2):330-7. PubMed ID: 16861534
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
18. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound.
Xiao L; Simmons C; Khanani S
Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
[TBL] [Abstract][Full Text] [Related]
20. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]